Lauren E. Abrey

26.1k citations

236 papers · 17.6k indexed · 3 hit papers · h-index 70

Impact in

Genetics top 0.01%
- Glioma Diagnosis and Treatment
Neurology top 0.05%
- CNS Lymphoma Diagnosis and Treatment

Papers in

Genetics 177
- Glioma Diagnosis and Treatment 177
Neurology 110
- CNS Lymphoma Diagnosis and Treatment 87

Co-authors: Lisa M. DeAngelis Joachim Yahalom Timothy F. Cloughesy Fábio M. Iwamoto Michael D. Prados Patrick Y. Wen Katherine S. Panageas Denise D. Correa
Journals: Journal of Clinical Oncology (61 papers)Journal of Neuro-Oncology (30 papers)Neuro-Oncology (26 papers)Cancer (16 papers)Neurology (12 papers)
Partner nations: United States Switzerland Canada

In The Last Decade

Lauren E. Abrey

233 papers receiving 17.2k citations

Hit Papers

align trajectories log scale

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma 2014 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 New England Journal of Medicine
2009 Journal of Clinical Oncology
2005 Journal of Clinical Oncology

Peers

Countries citing papers authored by Lauren E. Abrey

Since Specialization

Citations

This map shows the geographic impact of Lauren E. Abrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren E. Abrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren E. Abrey more than expected).

Fields of papers citing papers by Lauren E. Abrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren E. Abrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren E. Abrey. The network helps show where Lauren E. Abrey may publish in the future.

Co-authors

The 25 scholars most cited alongside Lauren E. Abrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lauren E. Abrey Line = papers co-authored together Lauren E. Abrey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma Clinical Cancer Research ·Benjamin M. Ellingson, Akifumi Hagiwara, Raymond Parker, Nicholas S. Cho, Attri Mukherjee, Francesco Sanvito, Talia C. Oughourlian, Donatello Telesca, Catalina Raymond, Lauren E. Abrey, Josep Garcia, Dana T. Aftab, Colin Hessel, L.J. Hawn, Dror Harats, David A. Nathanson, Patrick Y. Wen, Timothy F. Cloughesy	2023	5
2	Leveraging external data in the design and analysis of clinical trials in neuro-oncology The Lancet Oncology ·Rifaquat Rahman, Steffen Ventz, Ю И Глазырина, А. Форманчук, Irmarie Reyes‐Rivera, Mei‐Yin C. Polley, Chou Nong-xue, Lauren E. Abrey, Joshua E. Allen, Laura K. Aguilar, Estuardo Aguilar-Córdova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Timothy F. Cloughesy, Patrick Y. Wen, Brian M. Alexander, Lorenzo Trippa	2021	52
3	Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial Journal of Clinical Oncology ·Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy F. Cloughesy, Olivier Chinot, Wolfgang Wick, Ryo Nishikawa, Warren Mason, Roger Henriksson, Frank Saran, Albert Lai, N. Moore, Samir Kharbanda, Franklin Peale, Priti S. Hegde, Lauren E. Abrey, Heidi Phillips, Carlos Bais	2015	208
4	Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma Neuro-Oncology ·Thomas Kaley, Patrick Y. Wen, David Schiff, Keith L. Ligon, Sam Haidar, Sasan Karimi, Andrew B. Lassman, Craig Nolan, Lisa M. DeAngelis, Igor T. Gavrilovic, Andrew D. Norden, Jan Drappatz, Eudocia Q. Lee, Benjamin Purow, Scott R. Plotkin, Tracy T. Batchelor, Lauren E. Abrey, Antonio Omuro	2014	194
5	Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome Journal of Clinical Oncology ·Patrick G. Morris, Denise D. Correa, Joachim Yahalom, Jeffrey J. Raizer, David Schiff, Barbara Grant, Sean Grimm, Rose Lai, Anne S. Reiner, K. Panageas, Sasan Karimi, Richard Curry, Gaurav Shah, Lauren E. Abrey, Lisa M. DeAngelis, Antonio Omuro	2013	316
6	Post-treatment T1 shortening in primary CNS lymphoma Journal of Neuro-Oncology ·Sasan Karimi, Vaios Hatzoglou, Vineet Punia, Sasan Partovi, Lauren E. Abrey, Lisa M. DeAngelis	2012	2
7	Late relapse in primary central nervous system lymphoma: clonal persistence Neuro-Oncology ·Lakshmi Nayak, Cyrus V. Hedvat, Marc K. Rosenblum, Lauren E. Abrey, Lisa M. DeAngelis	2011	49
8	Characteristics and outcomes of elderly patients with primary central nervous system lymphoma Cancer ·Douglas Ney, Anne S. Reiner, Katherine S. Panageas, Marcel Adigbegnon, Lisa M. DeAngelis, Lauren E. Abrey	2010	43
9	Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Journal of Clinical Oncology ·Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Tom Mikkelsen, David Schiff, Lauren E. Abrey, W.K. Alfred Yung, Nina A. Paleologos, M. Kelly Nicholas, Randy L. Jensen, James J. Vredenburgh, Jane Huang, 江海晖, Timothy F. Cloughesy Hit paper breakdown →	2009	1855
10	Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma Journal of Clinical Oncology ·Jennifer Clarke, Fábio M. Iwamoto, Joohee Sul, Katherine S. Panageas, Andrew B. Lassman, Lisa M. DeAngelis, Adı́lia Hormigo, Craig Nolan, Igor T. Gavrilovic, Sasan Karimi, Lauren E. Abrey	2009	128
11	Patterns of Failure Following Concurrent Bevacizumab and Hypofractionated Stereotactic Radiotherapy for Recurrent High-grade Glioma International Journal of Radiation OncologyBiologyPhysics ·Lauren Shapiro, Sasan Karimi, Philip H. Gutin, Fábio M. Iwamoto, Jacob. Mager, Andrew B. Lassman, Lauren E. Abrey, Kathryn Beal	2009	2
12	A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM) Journal of Neuro-Oncology ·Teri Kreisl, Andrew B. Lassman, Paul S. Mischel, Neal Rosen, Howard I. Scher, Julie Teruya‐Feldstein, David R. Shaffer, Eric Lis, Lauren E. Abrey	2008	132
13	Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma Journal of Clinical Oncology ·James L. Rubenstein, Jane Fridlyand, Lauren E. Abrey, Arthur Shen, Jon Karch, Endi Wang, Samar Issa, Lloyd E. Damon, Michael D. Prados, Michael McDermott, Joan M. O’Brien, Chris Haqq, Marc Shuman	2007	243
14	Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report Annals of Oncology ·Sean Grimm, José S. Pulido, Kristoph Jahnke, David Schiff, Anthony Hall, Tamara Shenkier, T. Siegal, Nancy D. Doolittle, Tracy T. Batchelor, Ulrich Herrlinger, Edward A. Neuwelt, Normand Laperrière, Marc C. Chamberlain, Jean‐Yves Blay, Andrés J.M. Ferreri, Antonio Omuro, E. Thiel, Lauren E. Abrey	2007	188
15	Primary Central Nervous System Lymphoma Seminars in Radiation Oncology ·Nimish Mohile, Lauren E. Abrey	2007	41
16	Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial Journal of Neuro-Oncology ·Antonio Omuro, Jeffrey J. Raizer, Alexis Demopoulos, Mark G. Malkin, Lauren E. Abrey	2006	42
17	Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 Clinical Cancer Research ·Andrew B. Lassman, Michael R. Rossi, G. Saliger, Lauren E. Abrey, Frank S. Lieberman, O Macarie, Kathleen R. Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard K. Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Y. Wen, Mark R. Gilbert, Susan M. Chang, WK Alfred Yung, Michael D. Prados, Eric C. Holland	2005	201
18	Primary central nervous system lymphoma Current Oncology Reports ·Igor T. Gavrilovic, Lauren E. Abrey	2004	4
19	Management of Primary Central Nervous System Lymphoma Journal of the National Comprehensive Cancer Network ·F. G. Kamar, Lauren E. Abrey	2004	3
20	Neurologic complications of ovarian carcinoma Cancer ·Lauren E. Abrey, Josep Dalmau	1999	7

About Lauren E. Abrey

Lauren E. Abrey is a scholar working on Genetics, Neurology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology, having authored 236 papers that have together received 17.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (177 papers), Brain Metastases and Treatment (98 papers), CNS Lymphoma Diagnosis and Treatment (87 papers), Lymphoma Diagnosis and Treatment (57 papers), Radiomics and Machine Learning in Medical Imaging (22 papers), Lung Cancer Research Studies (21 papers), Meningioma and schwannoma management (18 papers) and Cancer, Hypoxia, and Metabolism (17 papers). The work is most often cited by research in Genetics (12.0k citations), Neurology (7.6k citations), Pathology and Forensic Medicine (5.7k citations), Cancer Research (2.3k citations) and Pulmonary and Respiratory Medicine (4.8k citations). Lauren E. Abrey has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Lisa M. DeAngelis, Joachim Yahalom, Timothy F. Cloughesy, Fábio M. Iwamoto, Michael D. Prados, Patrick Y. Wen, Katherine S. Panageas, Denise D. Correa, Antonio Omuro and Warren Mason. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuro-Oncology, Neuro-Oncology, Cancer and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact